Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Benzyl N-[(2S)-5-(diaminomethylamino)-1-[[(2S)-4-fluoro-3-oxobutan-2-yl]amino]-1-oxopentan-2-yl]carbamate
- Development stage
- Unknown
- Modality
- Small Molecules, Peptides
01
Overview
Benzyl N‑[(2S)‑5‑(diaminomethylamino)‑1‑[[(2S)‑4-fluoro-3-oxobutan-2-yl]amino]–1–oxopentan–2–yl]carbamate is a synthetic, experimental small molecule with a peptide-like structure. It is also known as benzoyl‐arginine‐alanine‐methyl ketone. The compound contains a fluoro-substituted methyl ketone moiety and an ornithine-derived guanidinium group, suggesting it may act as an inhibitor of serine or cysteine proteases by mimicking peptide substrates and covalently modifying the active site. There are no approved indications or clinical trials for this compound, and it is not approved by any major regulatory agency[6][5][2].
- Other names
- Benzoyl-arginine-alanine-methyl ketonebenzyl N-((1S)-4-((diaminomethyl)amino)-1-(((2S)-4-fluoro-3-oxobutan-2-yl)carbamoyl)butyl)carbamatebenzyl N-[ (1S ) -4-[ ( diaminomethyl ) amino ] -1-{ [ ( 2S ) -4-fluoro -3 -oxobutan -2 - yl ] carbamoyl } butyl ] carbamate
02
Targets
PRSS1 (Trypsin family)
Beyond the preview
Go deeper on Benzyl N-[(2S)-5-(diaminomethylamino)-1-[[(2S)-4-fluoro-3-oxobutan-2-yl]amino]-1-oxopentan-2-yl]carbamate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Benzyl N-[(2S)-5-(diaminomethylamino)-1-[[(2S)-4-fluoro-3-oxobutan-2-yl]amino]-1-oxopentan-2-yl]carbamate.